Bromocriptine Methanesulfonate
Bromocriptine Methanesulfonate Brand names, Bromocriptine Methanesulfonate Analogs
Bromocriptine Methanesulfonate Brand Names Mixture
- No information avaliable
Bromocriptine Methanesulfonate Chemical_Formula
C32H40BrN5O5
Bromocriptine Methanesulfonate RX_link
http://www.rxlist.com/cgi/generic3/bromocriptine.htm
Bromocriptine Methanesulfonate fda sheet
Bromocriptine Methanesulfonate msds (material safety sheet)
Bromocriptine Methanesulfonate Synthesis Reference
No information avaliable
Bromocriptine Methanesulfonate Molecular Weight
654.595 g/mol
Bromocriptine Methanesulfonate Melting Point
No information avaliable
Bromocriptine Methanesulfonate H2O Solubility
No information avaliable
Bromocriptine Methanesulfonate State
Solid
Bromocriptine Methanesulfonate LogP
No information avaliable
Bromocriptine Methanesulfonate Dosage Forms
Capsule
Bromocriptine Methanesulfonate Indication
For treatment of idiopathic or postencephalitic Parkinson's disease, dysfunctions associated with hyperprolactinemia and in the treatment of acromegaly.
Bromocriptine Methanesulfonate Pharmacology
Bromocriptine is an ergoline derivitave dopamine agonist that is used in the treatment of amenorrhea, female infertility, abnormal discharge of breast milk, hypogonadism, Parkinson's disease, and acromegaly. Bromocriptine produces its therapeutic effect in the treatment of Parkinson's disease, a clinical condition characterized by a progressive deficiency in dopamine synthesis in the substantia nigra, by directly stimulating the dopamine receptors in the corpus striatum.
Bromocriptine Methanesulfonate Absorption
No information avaliable
Bromocriptine Methanesulfonate side effects and Toxicity
No information avaliable
Bromocriptine Methanesulfonate Patient Information
Bromocriptine Methanesulfonate Organisms Affected
Humans and other mammals
